Autoimmune neutropenia in adults

被引:63
作者
Akhtari, Mojtaba [1 ]
Curtis, Brian [2 ]
Waller, Edmund K. [1 ]
机构
[1] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[2] Blood Ctr Wisconsin, Platelet & Neutrophil Immunol Lab, Milwaukee, WI USA
关键词
Neutropenia; Autoimmunity; G-CSF; ANTIBODIES; NEUTROPHILS; AUTOANTIBODIES; DEFICIENCY; INFECTION; DISEASE; SERA;
D O I
10.1016/j.autrev.2009.03.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune neutropenias (AIN) in adults are a heterogeneous group of diseases with clinical manifestations varying from being asymptomatic to having infectious complications with considerable morbidity and mortality. They are characterized by autoantibodies directed against neutrophils, resulting in destruction of neutrophils. AIN can be divided into two forms. In primary AIN, neutropenia is usually the sole hematologic abnormality and it is more common in children. Secondary AIN, which is more prevalent in adults, is associated with underlying autoimmune diseases, malignancies, infections, particularly viral, neurological diseases or drug exposure. This article is an overview of these conditions with emphasis on secondary AIN; it also discusses the available serological methods for antibody detection and recent therapeutic developments including colony stimulating factors, rituximab and Campath-1H. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:62 / 66
页数:5
相关论文
共 39 条
[21]   NATURAL-HISTORY OF CHRONIC IDIOPATHIC NEUTROPENIA [J].
KYLE, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (16) :908-909
[22]   Nomenclature for neutrophil-specific antigens [J].
Lalezari, P .
TRANSFUSION, 2002, 42 (11) :1396-1397
[23]  
Lalezari P, 2006, AUTOIMMUNE DISEASES, 4TH EDITION, P585, DOI 10.1016/B978-012595961-2/50046-9
[24]  
Liu JH, 2000, BLOOD, V95, P3219
[25]  
LOGUE GL, 1991, AM J MED, V90, P211
[26]   Primary antiphospholipid syndrome: A distinct entity? [J].
Mackworth-Young, C .
AUTOIMMUNITY REVIEWS, 2006, 5 (01) :70-75
[27]   CAMPATH-1H in the treatment of autoimmune cytopenias [J].
Marsh, JCW ;
Gordon-Smith, EC .
CYTOTHERAPY, 2001, 3 (03) :189-195
[28]  
MARTINO R, 1994, HAEMATOLOGICA, V79, P66
[29]   RETRACTED: TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus (Retracted article. See vol. 112, pg. 3529, 2008) [J].
Matsuyama, W ;
Yamamoto, M ;
Higashimoto, I ;
Oonakahara, K ;
Watanabe, M ;
Machida, K ;
Yoshimura, T ;
Eiraku, N ;
Kawabata, M ;
Osame, M ;
Arimura, K .
BLOOD, 2004, 104 (01) :184-191
[30]   Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus [J].
Ren, Y ;
Tang, JL ;
Mok, MY ;
Chan, AWK ;
Wu, A ;
Lau, CS .
ARTHRITIS AND RHEUMATISM, 2003, 48 (10) :2888-2897